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1. Introduction
Members of the Mycobacterium tuberculosis complex are successful pathogens due in a large
part to the complex interactions of an array of very special lipid molecular classes and
associated macromolecules that have been known for many years [1-6]. The cooperative
assembly of these components results in the presence of very robust cell envelopes. In
particular there is a specialised outer membrane; this can be termed a “mycomembrane”, but
in this review the abbreviation, MOM, for “mycobacterial outer membrane” will be used.
Subtle structural variations in mycobacterial lipid components point to important roles in the
integrity and function of the mycobacterial cell envelope. Over three decades ago, an attempt
was made to rationalise the role of the known constituent molecules with a proposal for a
“chemical” model of the cell envelope [4]. This general model has been supported in subse‐
quent studies but a wealth of new knowledge suggests that a significant upgrade is needed.
Each class of cell envelope structural units will be introduced, reasons for “why” such
structures are produced will be explored and an updated cell envelope model presented as a
working hypothesis. Close comparisons of the cell envelope compositions of M. tuberculosis
and related taxa will be interpreted in terms of evolution and pathogenicity. In various
diseases, the term “pathophysiology” is usually used to describe physiological changes in
affected hosts; here its meaning is turned around to explore the impact of aspects of myco‐
bacterial cell physiology in pathogenic members of the M. tuberculosis complex.
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Precise structures of the lipid moieties displayed in members of the M. tuberculosis complex
have become established during the past five decades, so it is now possible to explore the
significance of structure in the pathophysiological role of such lipids. Attention will focus on
lipids, whose regular occurrence in significant proportions indicates that they are integral
structural members of the mycobacterial cell envelope. Details of general biosynthetic
pathways will not be considered, nor will particular biological effects of individual lipid
classes. Recent cryo-electron microscopy studies have allowed the absolute dimensions of the
mycobacterial cell envelope to be estimated [7-9] so all components must adopt conformations
that allow their integration into an effective organelle. Tubercle bacilli also have a less clearly
defined capsule external to the more coherent cell envelope [10,11]; a detailed discussion of
this important region will not be attempted here. Similarly, a detailed exploration of protein
content is not given, even for structurally vital proteins such as well-characterised porins [12].
The main chemical structures that must be accommodated in the cell envelope of M. tubercu‐
losis are considered in the following sections, commencing with the long-chain mycolic acids
that are mycobacterial signature components [4,13-18].
2. Mycolic acids
The 70 to 90 carbon mycolic acids (MAs) are very characteristic chemical components in the
genus Mycobacterium. Members of the M. tuberculosis complex have three classes, the so-called
α-mycolates, methoxymycolates and ketomycolates (Figure 1) [4,13-18]. The latter two
varieties (Figure 1B) are comprised of subclasses having either cis-cyclopropane rings or
trans-cyclopropane rings with an adjacent methyl branch. In the case of the α-mycolates (Figure
1A), representative C80 mycolates from Mycobacterium kansasii and the M. tuberculosis complex
are compared to highlight the importance of key structural differences, whose importance will
be discussed later. All these MA classes occur naturally with at least five homologues and
variations in the numbers of carbons between the various functional groups. The majority of
MAs are covalently bound to arabinose termini of a mycoloylarabinogalactan-peptidoglycan
(mAGP) macromolecule to form a lipid monolayer inner leaflet of the MOM [4,19], as will be
described in detail later.
Recent physiochemical investigations have clearly demonstrated that mycolic acids charac‐
teristically adopt distinctly different folded conformations depending on structural niceties
[20-24]. Ketomycolates in M. tuberculosis predominately fold to yield a compact “W” confor‐
mation, with four chains in parallel [20,21,23,24]. Such tight packing can provide the founda‐
tion for an effective hydrophobic permeability barrier in the inner leaflet of the MOM. In
contrast, α- and methoxymycolates can form W-conformations but also more readily inhabit
a range of more extended conformations [20-23], some of which can be visualised as “U” or
“Z” shaped [24]. The α-mycolates tend towards an open fully extended U-conformation with
the two distal chains extended and methoxymycolates show intermediate behaviour between
the two other classes [22,24]. For the purpose of illustrating the importance of mycolate
conformation in MOM inner leaflet function (see later), ketomycolates are restricted to W-
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conformations, methoxymycolates are shown with both semi-folded sZ and fully folded W-
shapes [24] and α-mycolates have extended eU-conformations [24] (Figure 2).
Figure 2. Two-dimensional representative conformations of M. tuberculosis mycolic acids. A. Extended α-mycolate. B.
Two alternatives for methoxymycolates. C. Fully folded ketomycolate.
Figure 1. Representative structures of mycolic acids. A. α-Mycolates (C80), comparing M. kansasii and M. tuberculosis
complex. B, C. The main methoxy- and ketomycolates from M. tuberculosis.
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3. Esters of mycolic acids
The so-called “cord factors” are the best known mycolic acid esters in mycobacteria; they are
principally trehalose dimycolates (TDMs) with trehalose monomycolates (TMMs) also being
encountered (Figure 3). The proportions of TDMs and TMMs vary widely in mycobacteria so
an integral structural role is not indicated, their main importance lying in the key role as
intermediates in the transfer of mycolic acids on to arabinosyl units in the cell envelope [13].
Glucose monomycolates (GMMs) are common in mycobacteria, but in highly variable
proportions [25]. Consistent proportions, however, are recorded for monomycoloyl glycerols
(MMGs) (Figure 3) in the Mycobacterium bovis members of the M. tuberculosis complex [26,27],
thereby suggesting some cell envelope structural involvement. Mycobacteria also produce
very complex mixtures of di- and triacylglycerols, some of which contain non-hydroxylated
fatty acids that correspond to the meromycolate portion of mycolic acids [28,29], the so-called
“mycobacteric” acids [2]. Triacylglycerols have a storage role in “lipid bodies” [30] but they
have also been suggested as contributors to the MOM outer leaflet [31]; the complex mixtures
of di- and triacylglycerols must be fully unravelled before precise roles can be properly defined.
Figure 3. Mycolic acid esters. A. Trehalose dimycolate (TDM). B. Monomycoloyl glycerol (MMG).
4. Phthiocerol and phenolphthiocerol dimycocerosate families
The phthiocerol and phenolphthiocerol long-chain diols are esterified by multimethyl-
branched “mycocerosic” acids whose chiral centres have R absolute configuration in members
of the M. tuberculosis complex and M. kansasii (Figure 4) [32-35]. Phthiocerol dimycocerosates
(PDIMs) are mainly based on long-chain diols, the phthiocerol As and phthiodiolones (Figure
4). Related families of the phenolphthiocerol dimycocerosates have characteristic antigenic
oligosaccharides linked to the phenolic residue and these are commonly known as “phenolic
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glycolipids” (PGLs) (Figure 4) [33-36]. PDIMs are large (> 90 carbons) hydrophobic molecules
that are considered to be “free lipid” constituents of the outer leaflet of the external MOM,
interacting with the chains of the covalently bound MAs of the inner leaflet. The PDIMs from
the M. tuberculosis complex are relatively large in comparison with those of other taxa. Other
interesting cases are the so-called “Beijing” variants of M. tuberculosis [37] and M. kansasii [32,
33,35] where only restricted selections of members of the phthiocerol family are encountered.
Figure 4. Representative structures of mycocerosate esters of phthiocerols and glycosyl phenophthiocerols. A. Phthio‐
cerol family. B. Glycosyl phenophthiocerol (phenolic glycolipids). C. Simplified structures for illustrative use in Fig‐
ures 10 and 11.
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The oligosaccharide substituents of PGLs have demonstrable antigenicity [38] but the indi‐
vidual sugar units are relatively hydrophobic. Certain members of the M. tuberculosis complex,
such as the rare smooth morphology tubercle bacilli termed “Mycobacterium canettii”, have two
PGL types with different oligosaccharides but M. bovis, for example, has only a single type
(Figure 4). The PGLs from M. kansasii have close structural similarities to those from “M.
canettii” (Figure 4), but not to those from Mycobacterium marinum [33-36]. The chiral centres in
the multimethyl-branched fatty acid substituents in both the PGLs and PDIMs from M.
marinum and Mycobacterium ulcerans are of S absolute configuration [33-36]. Significantly, the
1,3-diol units in the phthiocerol and phenolphthiocerol moieties (Figure 4) from M. marinum
and M. ulcerans have erythro geometric configuration in contrast to the more common threo
stereochemistry [33-36].
5. Acyl trehaloses
In addition to TDMs and TMMs, there are families of trehalose-based glycolipids acylat‐
ed  with  multimethyl  branched  fatty  acids  with  S  absolute  configuration  of  their  chiral
centres  (Figure  5)  [34,39,40].  The  main  fatty  acids  encountered  are  C24  mycosanoic,  C27
mycolipenic,  C27  mycolipanolic,  C37  phthioceranic  and  C40  hydroxyphthioceranic  acids
(Figure 5). Diacyl trehaloses (DATs) are the simplest representatives, based on C24 mycosa‐
noic and C27 mycolipanolic acids. The C27 mycolipenates are the characteristic acyl compo‐
nents of pentaacyl trehaloses (PATs) (Figure 5). The exceptionally long phthioceranic and
hydroxyphthioceranic  acids  are  the  fatty  acids  found  in  a  family  of  sulfated  trehalose
glycolipids (SGLs) (Figure 5) [3,41].
6. Lipooligosaccharides
A highly polar series of lipids, which include trehalose in their saccharide core, are termed
lipooligosaccharides (LOSs) [42,43]. Such lipids are absent in many modern M. tuberculosis
isolates but they are characteristic of “M. canettii” and M. kansasii (Figure 6). Lipooligosac‐
charides are associated with biofilms and motility [44]. Indeed, it has been shown that smooth
variants of M. kansasii, containing LOSs, are rapidly cleared from the organs of infected
animals, but rough variants, lacking all LOSs, produce chronic systemic infections [45].
7. Phosphatidylinositol mannosides and other polar lipids
The mycobacterial plasma membrane incorporates conventional polar lipids, such as phos‐
phatidylethanolamine (PE), phosphatidylinositol (PI) and diphosphatidylglycerol (DPG)
(Figure 7), which can interact together to form the basis of a typical membrane bilayer.
However, most mycobacteria have a remarkably consistent family of four phosphatidylinosi‐
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tol mannosides (PIMs); these comprise mono- (AcPIM2) and diacyl phosphatidylinositol
dimannosides (Ac2PIM2) and mono- (AcPIM6) and diacyl phosphatidylinositol hexamanno‐
sides (Ac2PIM6) (Figure 7) [46-49]. Recent research has provided evidence that PIM2 and
PIM6 classes may be unevenly distributed over the two leaflets of the mycobacterial plasma
membrane [31]. These findings will be interpreted, later, as showing that PIMs may act to
reinforce the plasma membrane, perhaps adding a further level of selective permeability to
the mycobacterial cell envelope.
Figure 5. Acyl trehaloses. A. Diacyl trehalose (DAT). B. Pentaacyl trehalose (PAT). C. Sulfoglycolipid (SGL). D. Simpli‐
fied structures for illustrative use in Figures 10 and 11.
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8. Lipomannan and lipoarabinomannan
The basic structures of the PIMs polar lipid family (Figure 8) share the same manno-phospha‐
tidylinositol (MPI) anchor with two classes of characteristic large lipoglycans, namely lipo‐
mannans (LMs) and lipoarabinomannans (LAMs) (Figure 8) [50-54].
9. Mycoloylarabinogalactan-peptidoglycan (mAGP)
The overall chemical structure of this complex macromolecule has been clarified during the
past decade [55-58]. A specific linker unit covalently binds the proximal galactan portion of
the arabinogalactan to peptidoglycan with the distal arabinose moieties providing anchorage
for the 70 to 90 carbon long-chain mycolic acids (Figure 9) [19,55-58]. While chemical connec‐
Figure 6. Lipooligosaccharides (LOSs). A. M. kansasii. B. “M. canettii”. Simplified structures are included.
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Figure 7. Phosphatidylinositol mannosides (PIMs). A. Phosphatidylinositol dimannosides. B. Phosphatidylinositol
hexamannosides.C. Phosphatidylinositol. D. Phosphatidylethanolamine. E. Diphosphatidylglycerol. Simplified struc‐
tures are included.
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tivity is established, conformational preferences of the carbohydrate domains remain a matter
of conjecture with diverse interpretations. It is becoming evident that versatile peptidoglycans
can adopt different conformational arrangements, depending on the length of the polymeric
disaccharide chains with helices being possible for shorter units [59]. It was shown that a
synthetic peptidoglycan adopted a right-handed helical conformation [60]. A distinctive
feature of mycobacterial peptidoglycan is the presence of a proportion of N-glycolyl muramic
acid substituents, rather than the N-acetyl groups found in many other bacterial taxa [55-59].
The size and complexity of the mycoloylarabinogalactan- peptidoglycan, which is an extensive
single macromolecule, provides a major challenge in perceiving how it can be coherently
organised in three dimensions. This is not such a difficulty in many other bacterial taxa where
no really major macromolecules are directly attached to peptidoglycan. It is now well estab‐
lished that the mycolic acids form a coherent inner leaflet of the MOM and this necessitates
support from a well-integrated underlying platform.
The proposed mAGP arrangement (Figure 10) is based on a “scaffold” model [61,62], where
peptide cross-linked helices are interspersed with helices of the galactan part of the arabino‐
galactan; the arabinan portion is then arranged to provide linkage points for mycolic acids. An
Figure 8. Essential structural topography of M. tuberculosis lipomannan and lipoarabinomannan. MPI is manno-phos‐
phatidylinositol.
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attractive arrangement can be envisaged with the galactan extending to a level similar to that
of the peptidoglycan helix to produce an essentially level “mosaic platform” as a stable
anchorage for mycolic acids. While the helical galactan can provide a relatively rigid base unit,
the arabinan may be more flexible so that the bound mycolic acids can jostle for position and
occupy optimal locations. Indeed, arabinan flexibility may be an important factor in allowing
hydrophobic interactions to govern the relative location of mycolic acid chains and associated
free lipids. Calculations [63] indicate that the arabinofuranose polymer is reluctant to adopt a
rigid compact helical conformation, thereby allowing a degree of flexibility.
10. Cell envelope organisation
The original model [4], with an inner and outer membrane, was based mainly on chemical
principles, supported by freeze-etching results [64] that showed two clear distinct parallel
cleavage planes in the mycobacterial cell envelope. The dual membrane proposal was con‐
firmed by a confocal microscopy study that showed differential location of two fluorescent
dyes of different lipophilicity [65]. The outer membrane was visualised directly by cryo-
electron microscopy and the essential dimensions of the mycobacterial cell envelope were
revealed [7-9]. An updated model for the cell envelope organisation for tubercle bacilli is
proposed in Figure 10. Justification for the details of the proposal will build outwards from
the plasma membrane.
The inner plasma membrane in mycobacteria has been traditionally regarded as conventional,
even though a significant role was lacking for the unusual phosphatidylinositol mannosides
Figure 9. Essential structural topography of M. tuberculosis arabinogalactan-peptidoglycan.
Pathophysiological Implications of Cell Envelope Structure in Mycobacterium tuberculosis and Related Taxa
http://dx.doi.org/10.5772/59585
155
(PIMs) (Figure 7). A resolution of this conundrum has been indicated in a study [31], which
showed strong evidence for locating Ac2PIM2 (Figure 7) as the sole polar component of the
inner leaflet of the inner membrane. It was suggested that PIM6 would be present in the outer
leaflet of the inner membrane, projecting into the periplasm. It is not clear why there are two
versions of PIM2 and PIM6, with either three or four fatty acid chains (Figure 7), but as a working
hypothesis both PIM2 lipids are placed in the inner leaflet and both PIM6 lipids in the outer
leaflet of the plasma membrane (Figure 10). As demonstrated by two-dimensional thin-layer
chromatography [26], the proportions of the principal four PIM types are remarkably consis‐
tent, as is the proportion of PI. It is possible that equal proportions of PIMs with three and four
fatty acid constituents are optimal for close packing in membranes; detailed physical studies
on these lipids would be instructive. The proportions of PIM2 exceed those of PIM6 so if
PIM2 lipids are considered to predominate in the inner leaflet [31], then PI, PE and DPG (Figure
7) may complete the outer leaflet along with PIM6. There is a distinct possibility that myco‐
bacterial inner plasma membranes, rich in PIMs with three and four fatty acid chain anchors,
have special physical properties that enhance its stability and perhaps governs permeability.
Indeed, it has been suggested that this inner membrane may be “a bilayer environment of
unusually low fluidity” [31] contributing to drug resistance. It was also noted [31] that the
behaviour of PIM2 liposomes had been found [66] to have behaviour suggestive of exceptional
stability. It is now apparent that the inner mycobacterial plasma membrane is a highly
specialised organelle, worthy of being distinguished with special nomenclature. Given the
developing popularity of “MOM” for the mycobacterial outer membrane, a related simple
suggestion might be “MIM” for the “mycobacterial inner membrane”. It was found that
disruption of PIM2 production causes growth arrest [67,68] but the higher PIMs were dispen‐
sable [69], thereby indicating an important structural role for PIM2. It has also been indicated
that the acylation state of PIMs is also significant [70].
The outer leaflet of the MIM inner plasma membrane is also a suggested location for the PIM-
related LM and LAM (Figure 10), but unequivocal evidence is elusive with alternative MOM
location being a possibility. In a well-balanced objective analysis [71], it was concluded that
LAM had at least an initial anchorage in MIM. However, in some cases [72,73], the undoubted
presence of LAM at the cell surface required invoking specific lipoglycan transport mecha‐
nisms that need to be fully defined. At least a transient MIM location for LAM is supported
by the presence of related lipoglycans in other actinomycetes, which do not have mycolic acids
and an outer membrane, as summarised recently [72]. The basic fact that the lipid anchors of
LM and LAM are identical to those in PIMs (Figures 7,8) suggests very strongly that all these
components have a common anchorage in MIM. This should not rule out possible interactions
with the hydrophobic MOM surface, but such lipophilic binding is predictably less specific
and it is very difficult to envisage LM and LAM as important integral components of the MOM
outer leaflet. The PIM-based lipid anchors appear to be all very similar for related LM and
LAM lipoglycans across the genus Mycobacterium and related mycolata; however, enormous
variations in the surface of the MOM in such taxa would militate strongly against any specific
incorporation of LM and LAM into the MOM outer leaflet. Immunogold atomic force micro‐
scopy failed to detect cell surface LAM in M. bovis BCG, but LAM was revealed after treatment
with drugs that attack cell envelope targets [74]. For Corynebacterium glutamicum, it was found
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Figure 10. Two-dimensional representation of the location and interaction of structural components in the cell enve‐
lope of M. tuberculosis. MOM and MIM are “mycobacterial outer membrane” and “mycobacterial inner membrane”,
respectively. AGP is the arabinogalactan-peptidoglycan. Mycolic acid conformations (Figure 2) in the MOM are label‐
led “αu” for α-mycolate for fully extended “eU” shape, “Kw” and “Mw” for fully folded keto- and methoxymycolate
“W” shape, respectively, and “Ms” for semi-folded “sZ” shape. Correlating dimensions of all components are drawn to
fit within the spatial constraints imposed by cryo-electron microscopy [8,9]. Dimensions of peptidoglycan (PG) helices
are derived from synthetic material [60]. Helices of the mannan sections of lipomannan (LM) and lipoarabinomannan
(LAM) and both the arabinan and galactan components of arabinogalactan (AG) were modelled using GLYCAM.
Woods Group. (2005-2014) GLYCAM Web. Complex Carbohydrate Research Center, University of Georgia, Athens,
GA. (http://www.glycam.com) [63]. Details of simplified lipid structures are in Figures 4-6.
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that LM and LAM are embedded in the plasma membrane, along with the PIMs [75]. Overall,
the importance of lipophilic anchors in external LM and LAM is diminished by the observation
that their lipid-free glycan counterparts, mannan and arabinomannan, may be one destination
of these components [72].
The extensive supposed “periplasmic space” (Figure 10) will, in fact, be an area of intense
activity as all cellular components of the MOM whose synthesis is initiated in the cytoplasm,
and continued through MIM, may be assembled and organised within [51-54]. The fact that
many of these cell envelope components are relatively large may explain why such a relatively
extensive compartment is needed. Cryo-electron microscopy studies [7-9,76] gave indications
of some rather indistinct structural elements within the periplasm, labelled as layers L1 and
L2 [7,76]. The internal L1 layer is most probably associated with “granular” material of protein
origin, with the outer L2 layer corresponding to some of the peptidoglycan-arabinogalactan
matrix [76]. It has been proposed that the maintenance of the relatively low-density periplasmic
space could be facilitated by the presence of large polymeric material [9]. The helical mannan
polysaccharide moiety in LM (Figure 10) may have such a role, but it could also act as a scaffold
or template to compartmentalise various biochemical activities. In M. smegmatis it was shown
that LAM was dramatically reduced as the bacteria approached stationary phase, but LM,
mycolic acids and arabinogalactan were unchanged; this indicates that all these latter three
components have important structural roles [73].
The accommodation and conformation of the mycoloyl arabinogalactan peptidoglycan
macromolecular structure is a major challenge in the relatively limited space available (Figure
10). An informed choice has been made to use the “scaffold” approach of [61,62], with a helical
peptidoglycan network interspersed with helical galactan units, as detailed in Figure 10. The
relatively heavy peptidoglycan peptide cross-linking [52] may be a factor in favouring the
scaffold arrangement in mycobacteria. This proposal echoes a previously advanced arrange‐
ment [52] that did not attempt to make precise spatial correlations and neglected to include
the extensive periplasm. It would be interesting to explore the possibility that the N-glycolyl
muramic acid substituents may have some influence on mycobacterial peptidoglycan confor‐
mation. The proposed coherent peptidoglycan – galactan “mosaic platform” layer (Figure
10) could provide a coherent anchorage for the arabinan moieties, some of which are esterified
with mycolic acids. As noted previously, conformations of MAs vary with structural type and
these are illustrated with W-conformations for keto-MAs, an extended U-conformation for α-
MAs and equal numbers of W- and U-conformations for methoxy-MAs (Figure 2, 10). The MAs
are comprised of approximately 50% α-MAs [17,18] as reflected in Figure 10. Such covalently
bound MAs are instrumental in providing a stable MOM inner leaflet with potential for
interaction with diverse free lipids to produce an effective outer membrane permeability
barrier. Detailed spatial calculations attempted to simulate the accommodation of W-folded
α-MAs into the MOM [77]; however, other MA conformations must be incorporated to provide
a full picture. In a detailed quantitative study [31] of the cell envelope of M. smegmatis it was
demonstrated that there were sufficient hydrocarbon chains in both inner and outer mem‐
branes to confirm the viability of the original dual membrane model [4].
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A  wide  range  of  free  lipid  types  are  considered  to  form  the  outer  leaflet  of  the  outer
mycomembrane of members of the M. tuberculosis  complex. These range in polarity from
the hydrophilic LOSs (Figure 6), through PGLs (Figure 4), DATs, SGLs and PATs (Figure
5),  to  the  highly  apolar  hydrophobic  PDIMs  (Figure  4).  All  these  unusual  lipids  have
specialised  fatty  acid  components,  incorporating  varying  numbers  of  methyl  branches
located near to the carboxyl group (Figures 4-6).  For the original chemical model of the
mycobacterial  cell  envelope [4],  it  was conjectured that the presence of methyl branches
might moderate the depth of insertion of the fatty acids into the MOM bilayer. This remains
an attractive hypothesis,  though detailed physical studies would be of value. The proxi‐
mal multimethyl branches would favour a coiled conformation, leaving the distal straight-
chain portion of such fatty acids to interact with mycolic acid chains. The straight-chain
fatty acids in DATs, PATs (Figure 5) and LOSs (Figure 6) could possibly be layered parallel
to  the  MOM surface  providing  elements  of  lateral  stabilisation.  In  certain  previous  cell
envelope models [9,78] there has been an unjustified tendency to include inverted TDMs
as major components in the MOM outer leaflet. A proven role of TDMs is as an agent for
the transfer of mycolic acids onto the arabinan matrix, presumably in the assembly of the
inner leaflet of the MOM. It is more likely, therefore that TDMs would align themselves
with  the  trehalose  unit  adjacent  to  the  arabinan,  as  previously  indicated  [4].  Similarly,
monomycoloyl glycerols (MMGs) (Figure 3) in M. bovis would be more readily accommo‐
dated with an internal glycerol unit. Such a location might possibly act to modify MOM
fluidity in M. bovis whose mycolic acid composition has high proportions of cis-cycloprop‐
yl  keto-MAs,  in  comparison  with  the  predominant  trans-cyclopropyl  keto-MAs  in  M.
tuberculosis  [17,18].  However,  in  related  taxa,  such  as  Corynebacterium  glutamicum,  it  is
probable  that  the  structurally  much  simpler  mycolic  acids,  and  perhaps  their  trehalose
esters, are able to participate as members of the outer leaflet of the outer membrane [8,78].
11. Evolutionary and pathogenicity aspects of cell envelope composition
It is of particular interest to attempt to obtain an understanding of the influence and importance
of cell envelope composition in mycobacterial pathogenicity and evolution. A consensus is
developing that an attractive evolutionary pathway can be envisaged from environmental
Mycobacterium kansasii, through “M. canettii” to all the modern biotypes of the M. tuberculosis
complex [79-83]. M. kansasii is the environmental organism that phenotypically resembles M.
tuberculosis most closely and this relationship has been supported by genomic comparisons
[79-81]. Cogent arguments have been advanced to associate the evolution of ancient tubercle
bacilli, such as “M. canettii”, with bacteria similar to M. kansasii, including indications of
horizontal gene transfer between these taxa [80,81]. Key genes acquired by horizontal gene
transfer include those coding for mycobacterial lipids, transferases and proteins related to
adaptation to anaerobic conditions [80,81]. M. kansasii continues to cause pulmonary disease
in Silesian and South African miners, the bacterium being contracted from water in showers
[81]. A detailed study has shown that the unusual smooth morphology “M. canettii” strains
appear to form a pivotal role in the evolution of tuberculosis [84]. Although extant strains of
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“M. canettii” still cause human tuberculosis, they differ significantly in infectivity and appear
to be relatively ancestral [85,86]. Genomic studies indicate that the very diverse “M. canettii”
isolates appear to coalesce into a form of bottleneck after which all the modern human and
animal biotypes evolved in a relatively linear manner [83,84,87,88]. A plausible working
hypothesis for the evolution of M. tuberculosis sensu stricto is outlined in Figure 11, highlighting
the possible contribution of cell envelope lipid composition.
The most fundamental underlying difference between members of the M. tuberculosis complex,
broadly including “M. canettii”, and M. kansasii and related environmental taxa is seen in the
mycolic acids. The α-mycolic acids from M. kansasii have the regular spacing of the proximal
and distal cis-cyclopropyl groups (Figure 1), common to a wide range of mycobacteria [17,18].
In clear contrast, α-mycolates from “M. canettii” and members of the M. tuberculosis complex
have the chain between the hydroxyl group and the proximal cyclopropyl group shortened
most significantly from 17 methylene groups in, for example, M. kansasii to 11 and 13 methyl‐
enes in members of the M. tuberculosis complex [4,17,18,79]. Additionally, the chains in 2-
position and the terminal meromycolate chain are both relatively extended by two carbons.
As noted above [20,22,24,79], M. tuberculosis α-mycolic acids extend more readily in molecular
dynamics simulations with apparent interaction of the chain in 2-position with the chain
between the two cyclopropyl groups, in a “fully extended shape” (Figure 2) [22] or “eU”
conformation [24]. The methoxymycolates and ketomycolates of “M. canettii” and M. tubercu‐
losis (Figure 1) conform to the general pattern of these components in related mycobacteria,
such as M. kansasii, but, significantly, these oxygenated mycolates are slightly larger than any
others [17,18]. The particular ability of α-mycolates to adopt extended flexible U-conforma‐
tions is probably significant for interactions with free lipid components of the MOM outer
leaflet. Indeed it is possible that the exceptionally long terminal chain in M. tuberculosis α-
mycolic acids may penetrate right to the MOM outer leaflet to contribute to the hydrophobicity
of the cell envelope surface. In this context, the balance of the three main types of mycolates
is probably significant; the ratios of the α-, methoxy- and ketomycolates are, respectively,
~10:5:8 for M. kansasii, ~10:6:8 for “M. canettii” and ~10:5:5 for M. tuberculosis [17,18,79]. It is
conceivable that having 50% α-mycolates may optimise hydrophobic interactions with the
particular range of free lipids in the MOM outer leaflet in M. tuberculosis. In a detailed
consideration [79], it was found possible to discern quite a range of distinct differences in the
overall mycolic acid composition of these three taxa; the overall conclusion was an apparent
simplification and tightening up of mycolate composition in modern M. tuberculosis.
There are also very significant changes in cell envelope MOM free lipid composition between
all the taxa, shown in Figure 11. M. kansasii has characteristic polar LOSs (Figure 6), relatively
polar PGLs (Figure 4) and PDIMs based only on phthiodiolones (Figure 4). These three lipid
families appear to be the principal components of the outer leaflet of the MOM of M. kansasii,
possibly contributing to a relatively polar cell surface compatible with a native hydrophilic
environment. The PGLs of M. kansasii and “M. canettii” provide an appealing phenotypic link,
with a loss of a single sugar to give a triglycosyl PGL and three sugar units to give a mono‐
glycosyl PGL (Figures 4 and 11), as also highlighted previously [81]. However, some most
significant new lipid structural principles are introduced in “M. canettii” (Figure 11). Two
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major classes of acyl trehalose glycolipids, the DATs and PATs (Figure 5), are encountered [86].
The relatively polar DATs are good antigens, which probably contribute to the cell surface
properties of tubercle bacilli [38]. In contrast, the barely antigenic PATs are very non-polar and
are likely to increase cell surface hydrophobicity quite significantly. The reduced 9-sugar
oligosaccharide in the LOSs of “M. canettii”, compared with the 13-sugar oligosaccharide in
M. kansasii might also result in reduced hydrophilicity. It is not known if all the diverse isolates
of “M. canettii” have similar lipid profiles, but it certainly appears that the MOM free lipid
composition of this taxon has some redundancy with perhaps an over-generous provision of
lipid types (Figure 11). This redundancy might correlate with a high propensity for horizontal
gene transfer, positively accumulating new mycobacterial lipid principles at the expense of a
rather overblown excess of lipid biosynthesis. This might support a concept that “M. canet‐
tii” is a low pathogenicity intermediate taxon in evolutionary transit, rather than an efficient
pathogen with a particular niche. In contrast, as will be detailed below, the modern M.
tuberculosis complex has emerged out the ancestral melange as a group of efficient pathogens
with a range of specialised hosts.
Aspects of the cell envelope lipid composition of “M. canettii” are essentially the same as for
M. tuberculosis sensu stricto, including mycolic acid composition, but there are a number of key
differences. Significantly, the LOSs and PGLs present in “M. canettii” are absent in M. tuber‐
culosis, but the latter is uniquely characterised by the presence of SGLs [89]. As noted above,
the highly polar LOSs are associated with hydrophilic interactions, such as motility and biofilm
formation [44]. The PGLs are also relatively polar, but in addition to having a structural role
in the outer leaflet of the MOM, particularly specific functions are elusive. SGLs behave on
chromatography as quite polar lipids, presumably due to the presence of the sulfated trehalose
unit. However, SGLs have very large nonpolar phthioceranic and hydroxyphthioceranic fatty
acid acyl chains (Figure 5), which are likely to provide enhanced hydrophobicity. In two
informative studies, it was shown that deficiencies in SGLs [90] and DATs and PATs [91] did
not have decisive effects on replication and persistence. In bacterial disease, clear distinctions
must be made between transmissibility and the pathogenic process once the infection has been
established. It would appear that the very hydrophobic SGLs and PATs (Figure 5) may have
primary value in the transmission process, perhaps accompanied by some secondary roles in
pathogenicity.
Previous studies have shown an important link between hydrophobicity and aerosol per‐
formance in Mycobacterium avium [92]. Preliminary studies are under way to compare the
hydrophobicity of “M. canettii” and M. tuberculosis. For cultures grown on solid media in the
presence of Congo Red [93], the smooth colonies of M. kansasii and “M. canettii” resisted
staining by the dye, but two different rough strains of M. tuberculosis absorbed so much dye
that they almost merged into the background (Figure 12). In preliminary standard partitioning
experiments between hexadecane and water [94], it was found that M. tuberculosis was
approximately one fifth more hydrophobic than “M. canettii” (details not shown). These simple
experiments indicate a distinct difference in hydrophobicity between one member of the
smooth supposed ancestral “Cannetti” taxon and rough modern human tubercle bacilli. It
follows, therefore, that M. tuberculosis sensu stricto may be specifically adapted for aerosol
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transmission, whereas “M. canettii” is less favoured for this mode of transmission [85,86]. A
link between cell envelope hydrophobicity and aerosol transmission is also probably signifi‐
Figure 11. A generalised scenario for the significance of lipid composition in the evolution of M. tuberculosis. Details of
the simplified lipid structures are in Figures 4-6. The numbers of sugars in particular LOSs and PGLs are shown in
brackets with an asterisk, e.g. LOS (13)*.
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cant in Mycobacterium abscessus infections [95,96]. Airway infections are often associated with
rough variants that lack polar glycopeptidolipids and are likely to be more hydrophobic and
aerosol transmissible than the usual smooth strains [95,96]. It was also shown that rough
Gordona species were much more hydrophobic than smooth morphology variants of the same
strain [97]. By use of chemical force microscopy the cell envelope surface of M. bovis BCG was
found to be uniformly hydrophobic, but drugs disrupting mycolic acid synthesis destroyed
this feature [74].
A jump from environmental  M. kansasii  to  the  obligate  M. tuberculosis  human pathogen
requires the cooperation of suitable animal hosts, in which evolutionary changes can take
place.  The  total  dearth  of  any  evidence  for  tuberculosis  in  Homo  sapiens,  prior  to  the
Holocene, suggests zoonotic evolutionary hosts [79,98,99]. Characteristic skeletal lesions in
a variety of Pleistocene megafauna are suggesting the presence of tuberculosis over a wide
time period, going back to at least 120 ka BP [100,101]. In one well-documented example
of a 17ka extinct bison, diagnosis by lesion was conclusively confirmed by amplification of
M.  tuberculosis  complex  DNA  and  recovery  of  pristine  mycolipenate  (Figure  5)  and
mycocerosate (Figure 4) tuberculosis lipid biomarkers [99,102,103]. The complex digestive
organs in megafauna, such as bison and mastodons are potentially ideal vessels to facilitate
evolutionary development, as the rich population of other microbial species present would
be well situated to participate in horizontal gene transfer. There is substantial evidence for
Pleistocene horizontal gene transfer in ancestral strains of the tubercle bacillus before linear
evolution in the Holocene [80,81,104].
It is conceivable that, during the Pleistocene, thinly spread members of Homo sapiens, and also
Homo neanderthalensis, may have contracted evolving ancestral tuberculosis from infected
megafauna. However, there is no evidence to suggest that modern tuberculosis developed
from ancestral strains solely in the human vehicles, mentioned above. Indeed, recent studies
indicate that Neanderthals all became extinct before about 40ka BP [105], which precedes the
perceived ~30 to 12ka BP evolutionary bottleneck in tubercle bacilli [84,87,106]. A feasible
scenario, therefore, for the emergence of all the modern biotypes of the M. tuberculosis complex
through the bottleneck would involve a complex web of interactions between H. sapiens and
Pleistocene animal reservoirs until the dramatically ameliorated climatic conditions at the
Figure 12. Differential uptake of Congo Red by M. kansasii ATCC12478, “M. canettii” CIPT 140010059 MNC1485, M.
tuberculosis H37Rv and M. tuberculosis CDC1551. Strains were cultivated on 7H11 agar with 40µg/ml Congo Red.
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beginning of the Holocene allowed humans to form settlements and promulgate communal
tuberculosis. The apparent ready spread of human M. tuberculosis in early Holocene settle‐
ments was probably a result of the ability of the tubercle bacillus to fly in aerosols. This could
be a consequence of the dramatically enhanced hydrophobicity of M. tuberculosis sensu stricto
as compared with the most likely ancestral strains, labelled “M. canettii”. It will not be easy to
pinpoint a precise event when modern M. tuberculosis made its decisive debut on the human
stage. As noted above, the digestive systems of Pleistocene megafauna were probably very
efficient vessels for the evolution of tubercle bacilli and the change from the relatively
hydrophilic “M. canettii”, in the digestive tract, to the hydrophobic M. tuberculosis that could
be expelled from the lung. The enormous diversity of the extant surviving “M. canettii” taxon
[84] probably points to an even greater range of smooth ancestral strains being passaged,
recycled and adapted through animals and the environment. Indeed it probably reasonable to
suggest that the great genetic diversity of smooth strains of the tubercle bacilli may be a result
of their emergence over a wide time scale and geographical area.
12. Conclusion
The cell envelope of M. tuberculosis and related taxa is an assemblage of efficiently coordinated
and closely interacting macromolecules and exquisitely designed lipid moieties. One of the
most characteristic organelles is the “mycobacterial outer membrane” or “MOM”, but recent
studies have shown that the “mycobacterial inner membrane”, or “MIM”, may be comparable
in importance (Figure 10). Indeed the MIM, if it has a very characteristic inner leaflet composed
predominately of PIM2 phospholipids, may be a formidable barrier protecting the cytoplasm
(Figure 10). The MOM is composed of an outer leaflet of “free lipids”, which interacts with a
monolayer of mycolic acids covalently bound to the relatively flexible arabinan portion of an
arabinogalactan that, in turn, is linked to peptidoglycan. Utilising the hypothesis of the
“scaffold” model, the peptidoglycan and the galactan section of the arabinogalactan form
helices perpendicular to the cell surface resulting in a stable type of “mosaic platform” from
which the MOM can be linked via an arabinan cushion (Figure 10). The space between the MIM
and peptidoglycan, usually termed the “periplasm”, is envisaged as being the initial place for
the linkage of the characteristic lipoglycans, namely “lipomannan” (LM) and “lipoarabino‐
mannan” (LAM) (Figure 10). However, LAM certainly is transported to the external capsular
regions, but LM may linger in the periplasm affording a degree of organisation and stability.
Overall, it is important to note that the mycobacterial cell envelope is a dynamic three-
dimensional organelle; the hypothetical arrangement pictured in Figure 10 can only be a two-
dimensional snapshot illustrating likely locations and interactions.
Given the hypothesis that tubercle bacilli evolved from an environmental organism, such as
M. kansasii, via a mammalian adapted semi-environmental ancestral taxon, such as “M.
canettii”, parallel linked changes in the lipid components of the MOM can be discerned (Figure
11). A clear phenotypic link between M. kansasii and “M. canettii” is provided by clearly
comparable “phenolic glycolipids” (PGLs) (Figure 4). The introduction of distinct mycolic acid
Tuberculosis - Expanding Knowledge164
(Figure 1) and acyl trehalose (DATs, PATs, Figure 5) structures shows that “M. canettii” has
an indisputable link with modern members of the M. tuberculosis complex (Figure 11).
Refinement of the MOM lipid composition of “M. canettii”, leads to the simplified MOM free
lipids of M. tuberculosis, comprising PDIMs, DATs, PATs (Figures 4,5) and the very character‐
istic sulfoglycolipids (SGLs, Figure 5). The apparent enhanced hydrophobicity of the cell
envelope of M. tuberculosis sensu stricto correlates well with the ability to be transmitted in
aerosols. In broad evolutionary terms, a plausible scenario involves various Pleistocene
megafauna passaging environmental mycobacteria, such as M. kansasii, until horizontal gene
transfer resulted in the diverse family of smooth morphology strains labelled “M. canettii”.
Further evolutionary development, with possible human involvement for the first time,
produced modern M. tuberculosis whose novel ability to fly in aerosols probably coincided
with congregating settled humans multiplying together along with tubercle bacilli as new
devastating companions.
Acknowledgements
The Leverhulme Trust Project Grant F/00 094/BL (OY-CL, DEM, GSB). GSB was supported by
a Personal Research Chair from Mr. James Bardrick and the UK Medical Research Council.
The UK Medical Research Council and the Medical Research Foundation provided support to
AB.
Author details
David E. Minnikin1*, Oona Y-C Lee1, Houdini H.T. Wu1, Vijayashankar Nataraj1,
Helen D. Donoghue2, Malin Ridell3, Motoko Watanabe4, Luke Alderwick1, Apoorva Bhatt1 and
Gurdyal S. Besra1
*Address all correspondence to: d.e.minnikin@bham.ac.uk
1 Institute of Microbiology and Infection, School of Biosciences, University of Birmingham,
Birmingham, UK
2 Centre for Clinical Microbiology, Division of Infection and Immunity, University College
London, London, UK
3 Department of Microbiology and Immunology, Institute of Biomedicine, University of
Gothenburg, Gothenburg, Sweden
4 School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan
Pathophysiological Implications of Cell Envelope Structure in Mycobacterium tuberculosis and Related Taxa
http://dx.doi.org/10.5772/59585
165
References
[1] Anderson RJ. Structural peculiarities of acid-fast bacterial lipids. Chemical Reviews
1941;29: 225-243.
[2] Asselineau J. The Bacterial Lipids. Paris: Hermann; 1966.
[3] Goren MB, Brennan PJ. Mycobacterial lipids: Chemistry and biologic activities. In:
Tuberculosis. Youmans G.P. (ed.) Philadelphia USA: W.B. Saunders Company; 1979.
p63-193.
[4] Minnikin, DE. Lipids: Complex lipids, their chemistry, biosynthesis and role. In: Rat‐
ledge C, Stanford J. (eds.) The Biology of Mycobacteria. London, UK:, Academic
Press; 1982. p95-184.
[5] Daffé M, Draper P. The Envelope Layers of Mycobacteria with Reference to their
Pathogenicity. Advances in Microbial Physiology 1998;39: 131-203.
[6] Brennan PJ, Nikaido H. The Envelope of Mycobacteria. Annual Reviews of Biochem‐
istry 1995; 64: 29-63.
[7] Hoffmann C, Leis A, Niederweis M., Plitzko JM, Engelhardt H. Disclosure of the my‐
cobacterial outer membrane: Cryo-electron tomography and vitreous sections reveal
the lipid bilayer structure. PNAS 2008;105: 3963-3967.
[8] Zuber B, Chami M, Houssin C, Dubochet J, Griffiths G, Daffé M. Direct visualization
of the outer membrane of mycobacteria and corynebacteria in their native state. Jour‐
nal of Bacteriology 2008;190: 5672-5680.
[9] Daffé M, Zuber B. The Fascinating Coat Surrounding Mycobacteria. In: Remaut H.,
Fronzes R. (eds.) Bacterial Membranes: Structural and Molecular Biology. Linton,
Cambridge UK: Caister Academic Press; 2014. p179-192.
[10] Daffé M, Etienne G. The capsule of Mycobacterium tuberculosis and its implications for
pathogenicity. Tubercle and Lung Disease 1999:79: 153–169.
[11] Draper P, Daffé M. The Cell Envelope of Mycobacterium tuberculosis with Special Ref‐
erence to the Capsule and Outer Permeability Barrier. In: Cole ST, Eisenach KD,
McMurray DN, Jacobs WR. (eds.) Tuberculosis and the Tubercle Bacillus. Washing‐
ton, DC: American Society for Microbiology; 2005. p287-305.
[12] Niederweis M. Mycobacterial Porins. In: Daffé M., Reyrat, J-M. (eds.) The Mycobacte‐
rial Cell Envelope. Washington, DC: American Society for Microbiology; 2008.
p153-165.
[13] Kremer L, Besra GS. A Waxy Tale, by Mycobacterium tuberculosis. In: Cole ST, Eise‐
nach KD, McMurray DN, Jacobs WR. (eds.) Tuberculosis and the Tubercle Bacillus.
Washington, DC: American Society for Microbiology; 2005. p287-305.
Tuberculosis - Expanding Knowledge166
[14] Verschoor JA, Baird MS, Grooten J. Towards understanding the functional diversity
of cell wall mycolic acids of Mycobacterium tuberculosis. Progress in Lipid Research
2012;51: 325–339.
[15] Marrakchi H, Bardou F, Laneélle M, Daffé M. A comprehensive overview of mycolic
acid structure and biosynthesis. In: Daffé M, Reyrat JM. (eds). The Mycobacterial Cell
Envelope. Washington, DC: American Society for Microbiology; 2008. p41–62.
[16] Marrakchi H, Lanéelle M-A, Daffé M. Mycolic Acids: Structures, Biosynthesis, and
Beyond. Chemistry & Biology 2014;21: 67- 85.
[17] Watanabe M, Aoyagi Y, Ridell M, Minnikin DE. Separation and characterization of
individual mycolic acids in representative mycobacteria. Microbiology 2001;147:
1825–1837.
[18] Watanabe M., Aoyagi Y, Mitome H, Fujita T, Naoki H, Ridell M, Minnikin DE. Loca‐
tion of functional groups in mycobacterial meromycolate chains; the recognition of
new structural principles in mycolic acids. Microbiology 2002;148: 1881-1902.
[19] McNeil M, Daffé M, Brennan PJ. Location of the Mycolyl Ester Substituents in the
Cell Walls of Mycobacteria. Journal of Biological Chemistry 1991;266: 13217-13223.
[20] Villeneuve M., Kawai M, Kanashima H, Watanabe M, Minnikin DE, Nakahara H.
Temperature dependence of the Langmuir monolayer packing of mycolic acids from
Mycobacterium tuberculosis. Biochimica et Biophysica Acta Biomembranes 2005;1715:
71–80.
[21] Villeneuve M, Kawai M, Watanabe M, Aoyagi Y, Hitotsuyanagi Y, Takeya K, Gouda
H, Hirono S, Minnikin DE, Nakahara H. Conformational behavior of oxygenated my‐
cobacterial mycolic acids from Mycobacterium bovis BCG. Biochimica et Biophysica
Acta Biomembranes 2007;1768: 1717–1726.
[22] Villeneuve M, Kawai M, Watanabe M, Aoyagi Y, Hitotsuyanagi Y, Takeya K, Gouda
H, Hirono S, Minnikin DE, Nakahara H. Differential conformational behaviors of al‐
pha-mycolic acids in Langmuir monolayers and computer simulations. Chemistry
and Physics of Lipids 2010;163: 569–579.
[23] Villeneuve M, Kawai M, Horiuchi K, Watanabe M, Aoyagi Y, Hitotsuyanagi Y, Take‐
ya K, Gouda H, Hirono S, Minnikin DE. Conformational folding of mycobacterial
methoxy and ketomycolic acids facilitated by α-methyl trans-cyclopropane groups
rather than cis-cyclopropane units. Microbiology 2013;159: 2405–2415.
[24] Groenewald W, Baird MS, Verschoor JA, Minnikin DE, Croft AK. Differential sponta‐
neous folding of mycolic acids from Mycobacterium tuberculosis. Chemistry and Phys‐
ics of Lipids 2014;180: 15–22.
[25] Moody DB, Reinhold BB, Guy MR, Beckman EM, Frederique DE, Furlong ST, Ye S,
Reinhold VN, Sieling PA, Modlin RL, Besra GS, Porcelli SA. Structural requirements
Pathophysiological Implications of Cell Envelope Structure in Mycobacterium tuberculosis and Related Taxa
http://dx.doi.org/10.5772/59585
167
for glycolipid antigen recognition by CD1b-restricted T cells. Science 1997;278:
283-286.
[26] Dobson G, Minnikin DE, Minnikin SM, Parlett JH, Goodfellow M, Ridell M, Magnus‐
son M. Systematic analyses of complex mycobacterial lipids. In: Goodfellow M, Min‐
nikin DE. (eds.) Chemical Methods in Bacterial Systematics. London, UK: Academic
Press; 1985. p237- 265.
[27] Andersen CS, Agger EM, Rosenkrands I, Gomes JM, Bhowruth V, Gibson KJ, Peters‐
en RV, Minnikin DE, Besra GS, Andersen P. A Simple Mycobacterial Monomycoloy‐
lated Glycerol Lipid has Potent Immunostimulatory Activity. Journal of Immunology
2009; 182: 424-432.
[28] Kremer L, de Chastellier C, Dobson G, Gibson KJ, Bifani P, Balor S, Gorvel J-P, Locht
C, Minnikin DE, Besra GS. Identification and structural characterization of an unusu‐
al mycobacterial monomeromycoloyldiacylglycerol. Molecular Microbiology 2005;57:
1113–1126.
[29] Rafidinarivo E, Lanéelle M-A, Montrozier H, Valero-Guillén P, Astola J, Luquin M,
Promé J-C, Daffé M. Trafficking pathways of mycolic acids: structures, origin, mech‐
anism of formation, and storage form of mycobacteric acids. Journal of Lipid Re‐
search 2009;50: 477–490.
[30] Garton NJ, Christensen H, Minnikin DE, Adegbola RA, Barer MR. Intracellular lipo‐
philic inclusions of mycobacteria in vitro and in sputum. Microbiology 2002;148:
2951–2958.
[31] Bansal-Mutalik R, Nikaido H. Mycobacterial outer membrane is a lipid bilayer and
the inner membrane is unusually rich in diacyl phosphatidylinositol dimannosides.
PNAS 2014;111: 4958-4963.
[32] Minnikin DE, Dobson G, Goodfellow M, Magnusson M, Ridell M. Distribution of
Some Mycobacterial Waxes Based on the Phthiocerol Family. Journal of General Mi‐
crobiology 1985;131: 1375-1381.
[33] Daffé M, Lanéelle M-A. Distribution of Phthiocerol Diester, Phenolic Mycosides and
Related Compounds in Mycobacteria. Journal of General Microbiology 1988;134:
2049-2055.
[34] Minnikin DE, Kremer L, Dover LG, Besra GS. The methyl-branched fortifications of
Mycobacterium tuberculosis. Chemistry and Biology 2002; 9: 545-553.
[35] Onwueme KC, Cheryl J, Vos CJ, Zurita J, Ferreras JA, Quadri LEN. The dimycocero‐
sate ester polyketide virulence factors of mycobacteria. Progress in Lipid Research
2005;44: 259–302.
[36] Guilhot C, Chalut C, Daffé M. Biosynthesis and Roles of Phenolic Glycolipids and
Related Molecules in Mycobacterium tuberculosis. In: Daffé M, Reyrat J-M. (eds.) The
Tuberculosis - Expanding Knowledge168
Mycobacterial Cell Envelope. Washington, DC: American Society for Microbiology;
2008. p273-289.
[37] Huet SG, Constant C, Malaga W, Lanéelle M-A, Kremer K, van Soolingen D, Daffé
M, Guilhot C. A lipid profile typifies the Beijing strains of Mycobacterium tuberculosis.
Identification of a mutation responsible for a modification of the structures of phthio‐
cerol dimycocerosates and phenolic glycolipids. Journal of Biological Chemistry
2009;284: 27101–27113.
[38] Ridell M, Wallerström G, Minnikin DE, Bolton RC, Magnusson M. A comparative se‐
rological study of antigenic glycolipids from Mycobacterium tuberculosis. Tubercle and
Lung Disease 1992;73: 101-105.
[39] Jackson M, Stadthagen G, Gicquel B. Long-chain multiple methyl-branched fatty
acid-containing lipids of Mycobacterium tuberculosis: Biosynthesis, transport, regula‐
tion and biological activities. Tuberculosis 2007;87: 78–86.
[40] Daffé M, Lacave C, Lanéelle M-A, Gillois M, Lanéelle G. Polyphthienoyl trehalose,
glycolipids specific for virulent strains of the tubercle bacillus. European Journal of
Biochemistry 1988;172: 579-584.
[41] Bertozzi CR, Schelle MW. Sulfated Metabolites from M. tuberculosis: Sulfolipid-1 and
Beyond. In: Daffé M, Reyrat J-M. (eds.) The Mycobacterial Cell Envelope. Washing‐
ton, DC: American Society for Microbiology; 2008. p291-304.
[42] Daffé M, McNeil M, Brennan PJ. Novel Type-Specific Lipooligosaccharides from My‐
cobacterium tuberculosis. Biochemistry 1991;30: 378-388.
[43] Gilleron M, Puzo G. Lipooligosaccharidic antigens from Mycobacterium kansasii and
Mycobacterium gastri. Glycoconjugate Journal 1995;12: 298-308.
[44] Ren H, Dover LG, Islam ST, Alexander DC, Chen JM, Besra GS, Liu J. Identification
of the lipooligosaccharide biosynthetic gene cluster from Mycobacterium marinum.
Molecular Microbiology 2007;63: 1345-1359.
[45] Belisle JT, Brennan PJ. Chemical basis of rough and smooth variation in mycobacte‐
ria. Journal of Bacteriology 1989;171: 3465-3470.
[46] Gilleron M, Quesniaux VFJ, Puzo G. Acylation State of the Phosphatidylinositol Hex‐
amannosides from Mycobacterium bovis Bacillus Calmette Guérin and Mycobacterium
tuberculosis H37Rv and Its Implication in Toll-like Receptor Response. Journal of Bio‐
logical Chemistry 2003; 278: 29880-29889.
[47] Gilleron M, Ronet C, Mempel M, Monsarrat B, Gachelin G, Puzo G. Acylation state of
the phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette
Guérin and ability to induce granuloma and recruit natural killer T cells. Journal of
Biological Chemistry 2001;276: 34896-34904.
Pathophysiological Implications of Cell Envelope Structure in Mycobacterium tuberculosis and Related Taxa
http://dx.doi.org/10.5772/59585
169
[48] Guerin ME, Korduláková J, Alzari PM, Brennan PJ, Jackson M. Molecular Basis of
Phosphatidyl-myo-inositol Mannoside Biosynthesis and Regulation in Mycobacteria.
Journal of Biological Chemistry 2010;285: 33577-33583.
[49] Morita YS, Fukuda T, Sena CBC, Yamaryo-Botte Y, McConville MJ, Kinoshita T. Ino‐
sitol lipid metabolism in mycobacteria: Biosynthesis and regulatory mechanisms. Bi‐
ochimica et Biophysica Acta 2011;1810: 630–641.
[50] Nigou J, Gilleron M, Puzo G. Lipoarabinomannans: from structure to biosynthesis.
Biochimie 2003;85: 153-166.
[51] Mishra AK, Driessen NN, Appelmelk BJ, Besra GS. Lipoarabinomannan and related
glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiol‐
ogy and host-pathogen interaction. FEMS Microbiology Reviews 2011;35: 1126–1157.
[52] Kaur D, Guerin ME, Škovierová H, Brennan PJ, Jackson M. Biogenesis of the cell wall
and other glycoconjugates of Mycobacterium tuberculosis. Advances in Applied Micro‐
biology 2009;69: 23-78.
[53] Jankute M, Grover S, Rana AK, Besra GS. Arabinogalactan and lipoarabinomannan
biosynthesis: structure, biogenesis and their potential as drug targets. Future Micro‐
biology 2012;7: 129-147.
[54] Jankute M, Grover S, Birch HL, Besra GS. Genetics of Mycobacterial Arabinogalactan
and Lipoarabinomannan Assembly. In: Hatfull GF, Jacobs WR. (eds.) Molecular Ge‐
netics of Mycobacteria, 2nd Edition. Washington, DC: American Society for Microbiol‐
ogy; 2014. p535-557.
[55] Barry CE, Crick DC, McNeil MR. Targeting the formation of the cell wall core of M.
tuberculosis. Infectious Disorders and Drug Targets 2007;7: 182-202.
[56] Crick DC, Brennan PJ. Biosynthesis of the Arabinogalactan-Peptidoglycan Complex
of Mycobacterium tuberculosis. In: Daffé M., Reyrat, J-M. (eds.) The Mycobacterial Cell
Envelope. Washington, DC: American Society for Microbiology; 2008. p25-40.
[57] Crick DC, Chatterjee D, Scherman MS, McNeil MR. Structure and Biosynthesis of the
Mycobacterial Cell Wall. Comprehensive Natural Products II: Chemistry and Biology
2010;6: 381–406. DOI: 10.1016/B978-008045382-8.00173-8.
[58] Daffé M. The Global Architecture of the Mycobacterial Cell Envelope. In: Daffé M.,
Reyrat, J-M. (eds.) The Mycobacterial Cell Envelope. Washington, DC: American So‐
ciety for Microbiology; 2008. p3-11.
[59] Turner RD, Vollmer W, Foster SJ. Different walls for rods and balls: the diversity of
peptidoglycan. Molecular Microbiology 2014;91: 862-874.
[60] Meroueh SO, Bencze KZ, Hesek D, Lee M, Fisher JD, Timothy L. Stemmler TL, Mo‐
bashery S. Three-dimensional structure of the bacterial cell wall peptidoglycan.
PNAS 2006;103: 4404–4409.
Tuberculosis - Expanding Knowledge170
[61] Dmitriev BA, Ehlers S, Rietschel ET, Brennan PJ. Molecular mechanics of the myco‐
bacterial cell wall: from horizontal layers to vertical scaffolds. International Journal
of Medical Microbiology 2000;290: 251-258.
[62] Dmitriev B, Toukach F, Ehlers S. Towards a comprehensive view of the bacterial cell
wall. Trends in Microbiology 2005;13: 569-574.
[63] Kirschner KN, Yongye AB, Tschampel SM, Daniels CR, Foley BL, Woods RJ. GLY‐
CAM06: A Generalizable Biomolecular Force Field. Carbohydrates. Journal of Com‐
putational Chemistry 2008;29: 622-655.
[64] Barksdale L, Kim K-S. Mycobacterium. Bacteriological Reviews 1977; 41: 217–372.
[65] Christensen H, Garton NJ, Horobin RW, Minnikin DE, Barer MR. Lipid domains of
mycobacteria studied with fluorescent molecular probes. Molecular Microbiology
1999;31: 1561–1572.
[66] Sprott GD, Dicaire CJ, Gurnani K, Sad S, Krishnan L. Activation of Dendritic Cells by
Liposomes Prepared from Phosphatidylinositol Mannosides from Mycobacterium bo‐
vis Bacillus Calmette-Guérin and Adjuvant Activity in vivo. Infection and Immunity
2004;72: 5235–5246.
[67] Korduláková J, Gilleron M, Mikusova K, Puzo G, Brennan PJ, Gicquel B, Jackson, M.
Definition of the First Mannosylation Step in Phosphatidylinositol Mannoside Syn‐
thesis. Journal of Biological Chemistry 2002;277: 31335–31344.
[68] Guerin ME, Kaur D, Somashekar BS, Gibbs S, Gest P, Chatterjee D, Brennan PJ, Jack‐
son M. New insights into the early steps of phosphatidylinositol mannoside biosyn‐
thesis in mycobacteria: PimB' is an essential enzyme of Mycobacterium smegmatis.
Journal of Biological Chemistry 2009;284: 25687–25696.
[69] Driessen NN, Ummels R, Maaskant JJ, Gurcha SS, Besra GS, Ainge GD, Larsen DS,
Painter GF, Vandenbroucke-Grauls CM, Geurtsen J, Appelmelk BJ. Role of phospha‐
tidylinositol mannosides in the interaction between mycobacteria and DC-SIGN. In‐
fection and Immunity 2009;77: 4538–4547.
[70] Korduláková J, Gilleron M, Puzo G, Brennan PJ, Gicquel B, Mikusová K, Jackson M.
Identification of the required acyltransferase step in the biosynthesis of the phospha‐
tidylinositol mannosides of Mycobacterium species. Journal of Biological Chemistry
2003;278: 36285–36295.
[71] Gilleron M, Jackson M, Nigou J, Puzo G. Structure, Biosynthesis and Activities of the
Phosphatidyl-myo-Inositol-based Lipoglycans. In: Daffé M, Reyrat, J-M. (eds.) The
Mycobacterial Cell Envelope. Washington, DC: American Society for Microbiology;
2008. p75-105.
[72] Pitarque S, Larrouy-Maumus G, Payré B, Jackson M, Puzo G, Nigou J. The immuno‐
modulatory lipoglycans, lipoarabinomannan and lipomannan, are exposed at the
mycobacterial cell surface. Tuberculosis 2008;88: 560-565.
Pathophysiological Implications of Cell Envelope Structure in Mycobacterium tuberculosis and Related Taxa
http://dx.doi.org/10.5772/59585
171
[73] Dhiman RK, Dinadayala P, Ryan GJ, Lenaerts AJ, Schenkel AR, Crick DC. Lipoarabi‐
nomannan Localization and Abundance during Growth of Mycobacterium smegmatis.
Journal of Bacteriology 2011;193: 5802-5809.
[74] Alsteens D, Verbelen C, Dague E, Raze D, Baulard AR, Dufrêne YF. Organization of
the mycobacterial cell wall: a nanoscale view. Pflugers Arch- European Journal of
Physiology 2008;456: 117-125.
[75] Marchand CH, Salmeron C, Bou Raad R, Méniche X, Chami M, Masi M, Blanot D,
Daffé M, Tropis M, Huc E, Le Maréchal P, Decottignies P, Bayan N. Biochemical Dis‐
closure of the Mycolate Outer Membrane of Corynebacterium glutamicum. Journal of
Bacteriology 2012;194: 587-597.
[76] Sani M, Houben ENG, Geurtsen J, Pierson J, de Punder K, van Zon M, Wever B,
Piersma SR, Jiménez CR, Daffé M, Appelmelk BJ, Bitter W, van der Wel1 N, Peters
PJ. Direct Visualization by Cryo-EM of the Mycobacterial Capsular Layer: A Labile
Structure Containing ESX-1-Secreted Proteins. PLoS Pathogens 2010;6: e1000794.
[77] Bhamidi S, Scherman MS, Jones V, Crick DC, Belisle JT, Brennan PJ, McNeil MR. De‐
tailed structural and quantitative analysis reveals the spatial organization of the cell
walls of in vivo grown Mycobacterium leprae and in vitro grown M. tuberculosis. Journal
of Biological Chemistry 2011;286: 23168-23177.
[78] Dover LG, Cerdeño-Tárraga AM, Pallen MJ, Parkhill J, Besra GS. Comparative cell
wall core biosynthesis in the mycolated pathogens, Mycobacterium tuberculosis and
Corynebacterium diphtheriae. FEMS Microbiology Reviews 2004:28: 225–250.
[79] Minnikin DE, Lee OY-C, Wu HHT, Besra GS, Bhatt A, Nataraj V, Rothschild BM, Spi‐
gelman M, Donoghue HD. Ancient mycobacterial lipids: Key reference biomarkers in
charting the evolution of tuberculosis. Tuberculosis 2015;95: S133-S139.
[80] Veyrier F, Pletzer D, Turenne C, Behr MA. Phylogenetic detection of horizontal gene
transfer during the step-wise genesis of Mycobacterium tuberculosis. BMC Evolution‐
ary Biology 2009;9: 196.
[81] Veyrier FJ, Dufort A, Behr MA. The rise and fall of the Mycobacterium tuberculosis ge‐
nome. Trends in Microbiology 2011;19: 156-161.
[82] Bottai D, Stinear TP, Supply P, Brosch R. Mycobacterial Pathogenomics and Evolu‐
tion. In: Hatfull GF, Jacobs WR. (eds.) Molecular Genetics of Mycobacteria, 2nd Edi‐
tion. Washington, DC: American Society for Microbiology; 2014. p27-47.
[83] Smith NH, Hewinson RG, Kremer K, Brosch R, Gordon SV. Myths and misconcep‐
tions: the origin and evolution of Mycobacterium tuberculosis. Nature Reviews in Mi‐
crobiology 2009;7: 537-544.
[84] Supply P, Marceau M, Mangenot S, Roche D, Rouanet C, Khanna V, Majlessi L, Cris‐
cuolo A, Tap J, Pawlik A, Fiette L, Orgeur M, Fabre M, Parmentier C, Frigui W, Si‐
meone R, Boritsch EC, Debrie AS, Willery E, Walker D, Quail MA, Ma L, Bouchier C,
Tuberculosis - Expanding Knowledge172
Salvignol G, Sayes F, Cascioferro A, Seemann T, Barbe V, Locht C, Gutierrez MC, Le‐
clerc C, Bentley SD, Stinear TP, Brisse S, Médigue C, Parkhill J, Cruveiller S, Brosch
R. Genomic analysis of smooth tubercle bacilli provides insights into ancestry and
pathoadaptation of Mycobacterium tuberculosis. Nature Genetics 2013;45: 172-179.
[85] Fabre M, Hauck Y, Soler C, Koeck J-L, van Ingen J, van Soolingen D, Vergnaud G,
Pourcel C. Molecular characteristics of ‘‘Mycobacterium canettii’’ the smooth Mycobac‐
terium tuberculosis bacilli. Infection, Genetics and Evolution 2010;10: 1165–1173.
[86] Koeck J-L, Fabre M, Simon F, Daffé M, Garnotel E, Matan AB, Gérôme P, Bernatas JJ,
Buisson Y, Pourcel C. Clinical characteristics of the smooth tubercle bacilli ‘Mycobac‐
terium canettii’ infection suggest the existence of an environmental reservoir. Clinical
Microbiology and Infection 2011;17: 1013–1019.
[87] Gutierrez MC, Brisse S, Brosch R, Fabre M, Omaïs B, Marmiesse M, Supply P, Vin‐
cent V. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuber‐
culosis. PLoS Pathogens 2005;1(1): e5.
[88] Gordon SV, Bottai D, Simeone R, Stinear TP, Brosch R. Pathogenicity in the tubercle
bacillus: molecular and evolutionary determinants. BioEssays 2009;31: 378–388.
[89] Soto CY, Cama M, Gibert I, Luquin M. Application of an easy and reliable method
for sulfolipid-I detection in the study of its distribution in Mycobacterium tuberculosis
strains. FEMS Microbiology Letters 2000;187: 103-107.
[90] Rousseau C, Turner OC, Rush E, Bordat Y, Sirakova TD, Kolattukudy PE, Ritter S,
Orme IM, Gicquel B, Jackson M. Sulfolipid Deficiency Does Not Affect the Virulence
of Mycobacterium tuberculosis H37Rv in Mice and Guinea Pigs. Infection and Immuni‐
ty 2003; 71: 4684–4690.
[91] Rousseau C, Neyrolles O, Bordat Y, Giroux S, Sirakova TD, Prevost M-C, Kolat‐
tukudy PE, Gicquel B, Jackson M. Deficiency in mycolipenate- and mycosanoate-de‐
rived acyltrehaloses enhances early interactions of Mycobacterium tuberculosis with
host cells. Cellular Microbiology 2003;5: 405–415.
[92] Falkinham JO. Mycobacterial Aerosols and Respiratory Disease. Emerging Infectious
Diseases 2003;9: 763-767.
[93] Cangelosi GA, Palermo CO, Laurent J-P, Hamlin AM, Brabant WH. Colony morpho‐
types on Congo red agar segregate along species and drug susceptibility lines in the
Mycobacterium avium-intracellulare complex. Microbiology 1999;145: 1317-1324.
[94] Stokes RW, Norris-Jones R, Brooks DE, Beveridge TJ, Doxsee D, Thorson LM. The
Glycan-Rich Outer Layer of the Cell Wall of Mycobacterium tuberculosis Acts as an An‐
tiphagocytic Capsule Limiting the Association of the Bacterium with Macrophages.
Infection and Immunity 2004;72: 5676–5686.
Pathophysiological Implications of Cell Envelope Structure in Mycobacterium tuberculosis and Related Taxa
http://dx.doi.org/10.5772/59585
173
[95] Jönsson B, Gilljam M, Lindblad A, Ridell M, Wold AE, Welinder-Olsson C. Molecular
epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. Journal Clini‐
cal Microbiology 2007;45: 1497–1504.
[96] Jönsson B, Ridell M, Wold AE. Phagocytosis and cytokine response to rough and
smooth colony variants of Mycobacterium abscessus by human peripheral blood mono‐
nuclear cells. APMIS 2013;121: 45–55.
[97] Bendinger B, Rijnaarts HHM, Altendorf K, Zehnder AJB. Physicochemical Cell Sur‐
face and Adhesive Properties of Coryneform Bacteria Related to the Presence and
Chain Length of Mycolic Acids. Applied and Environmental Microbiology 1993;59:
3973-3977.
[98] Hershkovitz I, Donoghue HD, Minnikin DE, Besra GS, Lee OY-C, Gernaey AM, Gali‐
li E, Eshed V, Greenblatt CL, Lemma E, Kahila Bar-Gal G, Spigelman M. Detection
and molecular characterization of 9000-year-old Mycobacterium tuberculosis from a
Neolithic settlement in the Eastern Mediterranean. PLoS ONE 2008;3: e3426.
[99] Lee OY-C, Wu HHT, Donoghue HD, Spigelman, M, Greenblatt CL, Bull ID, Roths‐
child, BM, Martin, LD, Minnikin, DE, Besra, GS. Mycobacterium tuberculosis Complex
Lipid Virulence Factors Preserved in the 17,000-Year-Old Skeleton of an Extinct Bi‐
son, Bison antiquus. PLoS ONE 2012;7: e41923.
[100] Rothschild BM, Martin LD. Did ice-age bovids spread tuberculosis? Naturwissen‐
schaften 2006;93: 565-569.
[101] Rothschild BM, Laub R. Hyperdisease in the late Pleistocene: validation of an early
20th century hypothesis. Naturwissenschaften 2006;93: 557–564.
[102] Minnikin DE, Lee OY-C, Wu HHT, Besra GS, Donoghue HD. Molecular biomarkers
for ancient tuberculosis. In: Cardona P-J. (ed.) Understanding Tuberculosis – Deci‐
phering the Secret Life of the Bacilli. Rijeka, Croatia.: InTech -Open Access Publisher.
2012. p. 1-36. http://www.intechopen.com/books/understanding tuberculosis-deci‐
phering-the-secret-life-of-the-bacilli
[103] Rothschild BM, Martin LD, Lev G, Bercovier H, Bar-Gal GK, Greenblatt C, Donoghue
H, Spigelman M, Brittain D. Mycobacterium tuberculosis complex DNA from an extinct
bison dated 17,000 years BP. Clinical and Infectious Diseases 2001;33: 305–311.
[104] Jang J, Becq J, Gicquel B, Deschavanne P, Neyrolles O. Horizontally acquired genom‐
ic islands in the tubercle bacilli. Trends in Microbiology 2008;16: 303-308.
[105] Higham T, Douka K, Wood R, Ramsey CB, Brock F, Basell L, Camps M, Arrizabalaga
A, Baena J, Barroso-Ruíz C, Bergman C, Boitard C, Boscato P, Caparrós M, Conard
NJ, Draily C, Froment A, Galván B, Gambassini P, Garcia-Moreno A, Grimaldi S,
Haesaerts P, Holt B, Iriarte-Chiapusso MJ, Jelinek A, Jordá Pardo JF, Maíllo-Fernán‐
dez JM, Marom A, Maroto J, Menéndez M, Metz L, Morin E, Moroni A, Negrino F,
Panagopoulou E, Peresani M, Pirson S, de la Rasilla M, Riel-Salvatore J, Ronchitelli
A, Santamaria D, Semal P, Slimak L, Soler J, Soler N, Villaluenga A, Pinhasi R, Jacobi
Tuberculosis - Expanding Knowledge174
R. The timing and spatiotemporal patterning of Neanderthal disappearance. Nature
2014;512: 306-309.
[106] Djelouadji Z, Raoult D, Drancourt M. Palaeogenomics of Mycobacterium tuberculosis:
epidemic bursts with a degrading genome. Lancet Infectious Diseases 2011;11: 641–
650.
Pathophysiological Implications of Cell Envelope Structure in Mycobacterium tuberculosis and Related Taxa
http://dx.doi.org/10.5772/59585
175

